These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 30148428)
1. To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis? Boonstra M; Mertens BJA; Bakker JA; Ninaber MK; Ajmone Marsan N; van der Helm-van Mil AHM; Scherer HU; Huizinga TWJ; de Vries-Bouwstra JK Clin Exp Rheumatol; 2018; 36 Suppl 113(4):109-117. PubMed ID: 30148428 [TBL] [Abstract][Full Text] [Related]
2. Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests. Alkema W; Koenen H; Kersten BE; Kaffa C; Dinnissen JWB; Damoiseaux JGMC; Joosten I; Driessen-Diks S; van der Molen RG; Vonk MC; Smeets RL Autoimmunity; 2021 May; 54(3):148-155. PubMed ID: 33818234 [TBL] [Abstract][Full Text] [Related]
3. Serological profile of patients with systemic sclerosis. Wielosz E; Dryglewska M; Majdan M Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505 [TBL] [Abstract][Full Text] [Related]
4. Anti-PM-Scl antibody in patients with systemic sclerosis. Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302 [TBL] [Abstract][Full Text] [Related]
5. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274 [TBL] [Abstract][Full Text] [Related]
6. [High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis]. Dol C; Granel B; Resseguier N; Kaplanski G; Reynaud-Gaubert M; Schleinitz N; Grob JJ; Delaporte E; Lafforgue P; Rossi P; Bardin N; Benyamine A Rev Med Interne; 2024 Mar; 45(3):126-131. PubMed ID: 38355359 [TBL] [Abstract][Full Text] [Related]
7. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis. Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178 [TBL] [Abstract][Full Text] [Related]
8. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ; Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492 [TBL] [Abstract][Full Text] [Related]
9. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450 [TBL] [Abstract][Full Text] [Related]
10. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis. Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889 [TBL] [Abstract][Full Text] [Related]
11. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis. Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156 [TBL] [Abstract][Full Text] [Related]
12. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. Hamaguchi Y J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839 [TBL] [Abstract][Full Text] [Related]
13. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362 [TBL] [Abstract][Full Text] [Related]
14. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry. Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L; Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782 [TBL] [Abstract][Full Text] [Related]
15. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis. Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G; Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912 [TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil]. Coelho Horimoto AM; da Costa IP Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499 [TBL] [Abstract][Full Text] [Related]